Displaying 551 - 600 of 185641 results
Released Company Title Industry Topic
18 Oct 2024
07:30 CEST
MATVAREEXPRESSEN AS Meldepliktig handel for primærinnsidere 45201010 Food Retailers and Wholesalers Meldepliktig handel for primærinnsidere
18 Oct 2024
07:00 CEST
STRONGPOINT StrongPoint ASA: Third Quarter Results 2024 10101010 Computer Services Half yearly financial reports and audit reports/limited reviews
18 Oct 2024
07:00 CEST
MAGNORA Magnora ASA: Ex distribution NOK 0.187 today 60102020 Renewable Energy Equipment Ex Date
18 Oct 2024
07:00 CEST
MON COURTIER ENERGIE GROUPE S.A. Mon Courtier Energie Groupe Announces Its First-Half 2024 Results 50205020 Professional Business Support Services Income
18 Oct 2024
07:00 CEST
ATLANTIC SAPPHIRE Atlantic Sapphire ASA: Information about the warrants to be listed 45102010 Farming, Fishing, Ranching and Plantations Additional regulated information required to be disclosed under the laws of a Member State
18 Oct 2024
07:00 CEST
MON COURTIER ENERGIE GROUPE S.A. Mon courtier énergie groupe annonce ses résultats semestriels 2024 50205020 Professional Business Support Services Income
18 Oct 2024
06:59 CEST
NORSKE SKOG Financial calendar 55101015 Paper Additional regulated information required to be disclosed under the laws of a Member State
18 Oct 2024
06:59 CEST
NORSKE SKOG Finansiell kalender 55101015 Paper Annen informasjonspliktig regulatorisk informasjon
18 Oct 2024
06:55 CEST
NORSKE SKOG Higher market share in challenging publication paper market 55101015 Paper Additional regulated information required to be disclosed under the laws of a Member State
18 Oct 2024
06:55 CEST
NORSKE SKOG Høyere markedsandel i utfordrende markeder for publikasjonspapir 55101015 Paper Annen informasjonspliktig regulatorisk informasjon
18 Oct 2024
03:43 CEST
RAPID NUTRITION Rapid Nutrition PLC - Résultats de l'Assemblée Générale tenue le 18 octobre 2024 45102020 Food Products General meeting / Board Meeting
18 Oct 2024
03:40 CEST
RAPID NUTRITION Rapid Nutrition PLC - Results of General Meeting held 18 October 2024 45102020 Food Products General meeting / Board Meeting
17 Oct 2024
21:30 CEST
SALMONES CAMANCHACA S.A. Trading Update Q3 2024 45102010 Farming, Fishing, Ranching and Plantations Additional regulated information required to be disclosed under the laws of a Member State
17 Oct 2024
21:11 CEST
BE Semiconductor Industries N.V. BE Semiconductor Industries N.V. Announces 2024 Third Quarter Conference Call and Webcast Details 10102010 Semiconductors Other subject
17 Oct 2024
20:54 CEST
SAFE Signature d’un avenant n°3 au contrat de financement obligataire en vigueur pour assurer le retournement stratégique de Safe 20102015 Medical Supplies -
17 Oct 2024
20:53 CEST
ALTRI SGPS ALTRI, S.G.P.S., S.A. informa sobre transações de dirigentes 55101015 Paper Other subject
17 Oct 2024
20:45 CEST
VEON VEON Files its 2023 Form 20-F 15102015 Telecommunications Services Other subject
17 Oct 2024
20:39 CEST
AIRTHINGS Airthings ASA: Invitation to the presentation of the Q3 2024 results 50202025 Electronic Equipment: Gauges and Meters Non-regulatory press releases
17 Oct 2024
19:49 CEST
EUTELSAT COMMUNIC. Eutelsat Communications: Notice of Availability of the Universal Registration Document for the Year Ending June 30, 2024 15101010 Telecommunications Equipment Other subject
17 Oct 2024
19:49 CEST
EUTELSAT COMMUNIC. EUTELSAT COMMUNICATIONS : MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL POUR L’EXERCICE CLOS LE 30 JUIN 2024 15101010 Telecommunications Equipment Other subject
17 Oct 2024
19:48 CEST
EQVA ASA Eqva ASA: Redelivery of borrowed shares to close associate of primary insider 50206030 Marine Transportation Mandatory notification of trade primary insiders
17 Oct 2024
19:32 CEST
NEXT BIOMETRICS GROUP NEXT Biometrics Group ASA – Registration of new share capital 10102015 Electronic Components Total number of voting rights and capital
17 Oct 2024
19:28 CEST
AB SCIENCE AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA 20103010 Biotechnology New
17 Oct 2024
19:28 CEST
AB SCIENCE AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS 20103010 Biotechnology New
17 Oct 2024
18:44 CEST
CASINO GUICHARD Groupe Casino : Procédure de rachat obligatoire - Cnova 45201010 Food Retailers and Wholesalers New
17 Oct 2024
18:44 CEST
CASINO GUICHARD Casino Group: Statutory buyout proceedings - Cnova 45201010 Food Retailers and Wholesalers New
17 Oct 2024
18:39 CEST
SHELL PLC Transaction in Own Shares 60101000 Integrated Oil and Gas Other subject
17 Oct 2024
18:30 CEST
RUBIS RUBIS: Rubis completes the sale of its 55% stake in Rubis Terminal (now branded Tepsa) 40401030 Specialty Retailers Mergers, Acquiqitions, Transferts
17 Oct 2024
18:30 CEST
RUBIS RUBIS: Rubis finalise la cession de sa participation de 55 % dans Rubis Terminal (désormais appelé Tepsa) 40401030 Specialty Retailers Mergers, Acquiqitions, Transferts
17 Oct 2024
18:30 CEST
MEMSCAP REGPT MEMSCAP : VISIOCONFERENCE ACTIONNAIRES ET INVESTISSEURS LUNDI 28 OCTOBRE 2024 18H00 10102010 Semiconductors Meetings / events
17 Oct 2024
18:29 CEST
INTEGRAGEN IntegraGen: 2024 Half-Year Results - Sales up 6% on a Like-for-Like Basis (Excluding SeqOIA) and Profitability Maintained 20103010 Biotechnology Income
17 Oct 2024
18:29 CEST
INTEGRAGEN IntegraGen : Résultats du 1er semestre 2024 – Chiffre d’affaires en hausse de 6% à périmètre constant (hors SeqOIA) et rentabilité maintenue 20103010 Biotechnology Income
17 Oct 2024
18:17 CEST
FDJ La Française des Jeux: Revenue to End-September up 12%, and 6% on a Like-for-like Basis 40501020 Casinos and Gambling Sales
17 Oct 2024
18:17 CEST
FDJ La Française des Jeux : Chiffre d’affaires à fin septembre en hausse de +12 % et +6 % à périmètre comparable 40501020 Casinos and Gambling Sales
17 Oct 2024
18:00 CEST
BIOSYNEX BIOSYNEX SA: RESULTATS SEMESTRIELS 2024 - FINALISATION DU PLAN DE RATIONALISATION DES COUTS ET DE REAMENAGEMENT DE LA DETTE SUR LES PROCHAINS MOIS 20102010 Medical Equipment Income
17 Oct 2024
18:00 CEST
DIAGNOSTIC MEDICAL SYSTEMS CHIFFRE D'AFFAIRES DU 3ÈME TRIMESTRE 2024 : DMS GROUP POURSUIT SA CROISSANCE 20102010 Medical Equipment Sales, Income
17 Oct 2024
18:00 CEST
ESSILORLUXOTTICA EssilorLuxottica: Q3/9M 2024 Revenue - Revenue keeping a solid 4% growth 20102015 Medical Supplies Commercial results
17 Oct 2024
18:00 CEST
TELEPERFORMANCE L’initiative Science Based Targets valide les nouveaux objectifs d’émissions carbone de Teleperformance 50205020 Professional Business Support Services Products and services
17 Oct 2024
18:00 CEST
OSE IMMUNOTHERAPEUTICS OSE Immunotherapeutics Presents New “Cis-Demasking” Bispecific Technology for the Design of Cytokine Drugs with Improved Therapeutic Index 20103010 Biotechnology Other subject
17 Oct 2024
18:00 CEST
OSMOSUN S.A. 10 millions de M3 d'eau douce produite pour l'unité de dessalement OSMOSUN du Lac du Goubet à Djibouti 65102030 Water Legal
17 Oct 2024
18:00 CEST
THERANEXUS THERANEXUS JOINS UP WITH SYNERLAB TO PREPARE THE COMMERCIALIZATION OF ITS PEDIATRIC FORMULATION IN NIEMANN-PICK TYPE C DISEASE 20103010 Biotechnology Legal
17 Oct 2024
18:00 CEST
I2S i2S : Chiffre d\'affaires 9 mois 2024 50202025 Electronic Equipment: Gauges and Meters Share history
17 Oct 2024
18:00 CEST
OSMOSUN S.A. 10 million M3 of fresh water produced for the OSMOSUN desalination plant at Lake Ghoubet in Djibouti 65102030 Water Legal
17 Oct 2024
18:00 CEST
ESSILORLUXOTTICA EssilorLuxottica: Chiffre d’affaires T3/9M 2024 - Solide croissance du chiffre d'affaires à +4 % 20102015 Medical Supplies Commercial results
17 Oct 2024
18:00 CEST
TELEPERFORMANCE Teleperformance’s New Carbon Emissions Targets Approved by Science Based Targets Initiative 50205020 Professional Business Support Services Products and services
17 Oct 2024
18:00 CEST
OSE IMMUNOTHERAPEUTICS OSE Immunotherapeutics présente une nouvelle technologie bispécifique de « Cis-Démasquage » pour la conception de médicaments à base de cytokines avec un indice thérapeutique amélioré 20103010 Biotechnology Other subject
17 Oct 2024
18:00 CEST
LLAMA GROUP Llama Group : Faits marquants du premier semestre 2024 40203040 Electronic Entertainment New
17 Oct 2024
18:00 CEST
European Medical Solutions CHIFFRE D'AFFAIRES DU 3ÈME TRIMESTRE 2024 : EMS POURSUIT SA CROISSANCE 20103010 Biotechnology Sales, Income
17 Oct 2024
18:00 CEST
THERANEXUS THERANEXUS S'ASSOCIE À SYNERLAB POUR PRÉPARER LA COMMERCIALISATION DE SA FORMULATION PÉDIATRIQUE DANS LA MALADIE DE NIEMANN-PICK DE TYPE C 20103010 Biotechnology Legal
17 Oct 2024
18:00 CEST
ESSILORLUXOTTICA EssilorLuxottica: Fatturato del terzo trimestre e dei nove mesi 2024 - Solida traiettoria di crescita, fatturato in aumento del 4% 20102015 Medical Supplies Commercial results